CCMDS AML in Partnership with CLSG/GCEL
On behalf of the organizing committee, we welcome you to the Canadian Conference on Myelodysplastic Syndromes (CCMDS) and Acute Myeloid Leukemia (AML). We are happy to announce, the CCMDS/AML Conference has collaborated with the Canadian Leukemia Study Group (CLSG). CCMDS/AML will take place on September 10-12, 2027 at the Fairmont Chateau Laurier in Ottawa, Ontario. This meeting follows on the momentum and success generated by the last several CCMDS/AML meetings.
CCMDS/AML will host international experts in MDS and AML from Europe, the United States and Canada. These leaders will review the newest developments in this rapidly evolving field.
Case presentations will highlight current treatment standards and feature discussions of where the new therapies could be positioned. There will be opportunity for audience participation via polling with members of the clinical faculty featured during the panel discussion. We aim to bring a Canadian perspective to the management of MDS & AML patients. These meetings have clear implications for the delivery of care to patients with MDS and AML in Canada and fosters opportunities for collaboration and research.
The planning committee is looking forward to your input as to ways in which we can work together to optimize the care of our patients.
We look forward to seeing you in Ottawa for CCMDS/AML!
Yours truly,
Dr. Mitchell Sabloff, CCMDS/AML 2027 Co-Chair, Ottawa, ON
Dr. Hubert Tsui, CCMDS/AML 2027 Co-Chair, Toronto, ON
On behalf of the CCMDS/AML Planning Committee,
Dr. Rena Buckstein, Toronto, ON
Dr. Grace Christou, Ottawa, ON
Dr. Michelle Geddes, Calgary, AB
Dr. Brett Houston, Winnipeg, MB
Dr. Aly Karsan, Vancouver, BC
Dr. Wendy Lam, Burnaby, BC
Dr. Brian Leber, Hamilton, ON
Dr. Heather Leitch, Vancouver, BC
Dr. David Sanford, Vancouver, BC
Dr. Andre Schuh, Toronto, ON
Dr. April Shamy, Montreal, QC
Dr. Amy Trottier, Halifax, NS
Target Audience
This meeting has been designed to meet the educational needs of hematologists, internists, researchers, general practitioners in oncology, practitioners in laboratory medicine, residents, fellows, nurses, pharmacists and other health care providers involved in the management of patients with MDS & AML.
Learning Objectives
CCMDS/AML, a collaboration between Canadian Consortium on Myelodysplastic Syndromes and Canadian Leukemia Study Group
At the completion of the meeting, attendees should be able to (MDS):
- Review current understanding of the role of molecular mutations in MDS biology and prognosis
- Review the role of inflammation in MDS pathogenesis and progression
- Review MDS overlap syndromes
- Update treatment strategies in MDS including novel agents
- Gain insight into mechanisms of treatment resistance
- Review the role of intensive therapies and stem cell transplantation in MDS
- Review pre-MDS conditions including CHIP, CCUS, and ICUS
- Review mechanisms of atherosclerosis in the context of cardiac morbidity in MDS
- Review current understanding of the role of iron overload in MDS
- Discuss a Canadian perspective on MDS landscape & treatment
At the completion of the meeting, attendees should be able to (AML):
- Review the biology of AML
- Review novel treatments for AML
- Review the role of leukemic stem cells in AML pathogenesis and progression
- Review cellular therapy for AML
- Review the role of intensive therapies and stem cell transplantation in elderly/t/s-AML, including conditioning regimens and patient selection for these therapies.
- Discuss a Canadian perspective on AML landscape and treatment
Accommodations
Fairmont Chateau Laurier Ottawa
1 Rideau St, Ottawa, ON K1N 8S7
CCMDS/AML is pleased to have negotiated a discounted room rate starting at $329/night + taxes for our delegates.
Reservations must be made by Monday August 9th, 2027
Booking link will open Sept 15th, 2026.
Cancellations:
The hotel will accept cancellations made up to 48 hours before arrival.
The hotel will accept cancellations made up to 48 hours before arrival.
Or Call Global Reservations Centre at 1-800-441-1414.
Please identify as being a part of the CCMDS/AML Conference or CCMDS0927
